Status:
WITHDRAWN
A Naturalistic Prospective Study of Treatment Effectiveness for Attention-Deficit/Hyperactivity Disorder (ADHD)
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
Janssen-Ortho Inc., Canada
Conditions:
Attention-Deficit/Hyperactivity Disorder (ADHD)
Eligibility:
All Genders
16-18 years
Brief Summary
To determine if there is a clinically and statistically significant difference between OROS-MPH and IR MPH in ADHA and ODD symptoms by the parent completed SNAP-IV. It is hypothesized that OROS-MPH is...
Detailed Description
This one-year prospective observational study is designed to evaluate and compare outcomes effectiveness between OROS-MPH and IR MPH in ADHA and ODD symptoms at the ADHD Clinic of the British Columbia...
Eligibility Criteria
Inclusion
- Patients between the ages of 6 and 18.
- Enrolled in school with at least 1 school year remaining before completion of high school.
- Current drug therapy with either a IR MPH or OROS MPH.
Exclusion
- Parent/caregiver unable or unwilling to provide written informed consent.
- Child unable or unwilling to provide assent (for children aged 7 years).
- Parent/caregiver unable or unwilling to complete questionnaires.
- Child unable or unwilling to complete questionnaires ADHD is considered by the clinician to be secondary to another more serious disorder such as personality disorder, substance abuse, bipolar disorder, autism, or mental handicap.
- Participation in another treatment study.
Key Trial Info
Start Date :
December 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00323700
Start Date
December 1 2008
End Date
December 1 2010
Last Update
April 21 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.